Compare Kimberly Clark Corp (KMB) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kimberly Clark Corp vs Nuwellis Inc — how do they compare? Kimberly Clark Corp trades at $109.33 (market cap $36.01B), while Nuwellis Inc trades at $2.94 (market cap $1.09M). The key difference: Kimberly Clark Corp is far larger — about 33036.7× Nuwellis Inc's market cap, and Kimberly Clark Corp pays a 4.72% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| KMB | NUWE | |
|---|---|---|
Market Cap | $36.01B | $1.09M |
Sector | Consumer Staples | Technology |
52-Week High | $136.77 | $527.46 |
52-Week Low | $93.05 | $2.80 |
Enterprise Value | $42.55B | -$722.58K |
Dividend Yield | 4.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kimberly-Clark (KMB) trades at $108.05, down 0.28% on the day, with a neutral technical signal. The stock shows strong profitability with a net income margin of 12.8% and has beaten earnings estimates for the last three quarters. Recent news highlights its status as a Dividend King and strategic moves like the Arbex joint venture. Cash flow trends indicate operational strength despite recent net outflows.
KMB offers a stable investment with a solid dividend yield and consistent earnings beats, but faces risks from high payout ratios and competitive pressures. Analyst consensus is mixed with a hold-heavy rating, though the $115.33 price target suggests modest upside. Revenue declines in 2025 warrant monitoring for sustained growth.
NUWE trades at $3.00, up 5.26% over 24 hours, following a recent 35:1 reverse stock split effective June 26, 2026. The stock shows a bearish technical signal with all moving averages indicating sell. Fundamentally, the company reported a net loss of $17.52M in 2025, with negative profit margins, though revenue grew to $8.27M. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026.
Outlook remains challenging due to persistent losses and high cash burn, but strategic initiatives in pediatric cardiorenal care and new patents offer growth potential. Key risks include negative ROE, reliance on financing, and competitive pressures. Analyst consensus is split evenly between Buy and Hold, reflecting cautious optimism amid financial headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
